Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 16 December 2022; doi:10.1038/s41391-022-00631-5Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 16, 2022 Category: Urology & Nephrology Authors: Angela Y. Jia Daniel E. Spratt Source Type: research

Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database
Prostate Cancer and Prostatic Diseases, Published online: 16 December 2022; doi:10.1038/s41391-022-00628-0Trends in prostate cancer mortality in the United States of America, by state and race, from 1999 to 2019: estimates from the centers for disease control WONDER database (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 16, 2022 Category: Urology & Nephrology Authors: Chinmay Jani Christian Mouchati Nour Abdallah Melissa Mariano Ruchi Jani Justin D. Salciccioli Dominic C. Marshall Harpreet Singh Iris Sheng Joseph Shalhoub Rana R. McKay Source Type: research

Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting
Prostate Cancer and Prostatic Diseases, Published online: 14 December 2022; doi:10.1038/s41391-022-00622-6Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 14, 2022 Category: Urology & Nephrology Authors: Stephen J. Freedland Agnes Hong Nader El-Chaar Sharanya Murty Krishnan Ramaswamy Anna D. Coutinho David Nimke Alicia K. Morgans Source Type: research

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis
Prostate Cancer and Prostatic Diseases, Published online: 12 December 2022; doi:10.1038/s41391-022-00626-2Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 12, 2022 Category: Urology & Nephrology Authors: Tam ás Fazekas Ádám D. Széles Brigitta Teutsch Anita Csizmarik B álint Vékony Alex V áradi Tam ás Kói Zsolt Lang N ándor Ács Zsolt Kopa P éter Hegyi Boris Hadaschik Viktor Gr ünwald P éter Nyirády Tibor Szarvas Source Type: research

Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling
Prostate Cancer and Prostatic Diseases, Published online: 12 December 2022; doi:10.1038/s41391-022-00620-8Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 12, 2022 Category: Urology & Nephrology Authors: Jean-Paul Noujeim Yassir Belahsen Yolene Lefebvre Marc Lemort Maxime Deforche Nicolas Sirtaine Robin Martin Thierry Roumegu ère Alexandre Peltier Romain Diamand Source Type: research

Prostatic high-resolution micro-ultrasound: an attractive step-forward in the management of prostate cancer patients
Prostate Cancer and Prostatic Diseases, Published online: 12 December 2022; doi:10.1038/s41391-022-00611-9Prostatic high-resolution micro-ultrasound: an attractive step-forward in the management of prostate cancer patients (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 12, 2022 Category: Urology & Nephrology Authors: Ferdinando Fusco Mark Emberton Davide Arcaniolo Cosimo De Nunzio Celeste Manfredi Massimiliano Creta Source Type: research

Fact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen
Prostate Cancer and Prostatic Diseases, Published online: 09 December 2022; doi:10.1038/s41391-022-00629-zFact, overdiagnosis cannot be evaluated by comparing histological grading of prostate biopsy to prostatectomy specimen (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 9, 2022 Category: Urology & Nephrology Authors: Hein Vincent Stroomberg Klaus Brasso Andreas R øder Source Type: research

Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 08 December 2022; doi:10.1038/s41391-022-00627-1Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 8, 2022 Category: Urology & Nephrology Authors: Jacob E. Tallman Christopher J. D. Wallis Zhiguo Zhao Li-Ching Huang David F. Penson Tatsuki Koyama Michael Goodman Ann S. Hamilton Xiao-Cheng Wu Lisa E. Paddock Antoinette Stroup Matthew R. Cooperberg Mia Hashibe Brock B. O ’Neil Sherrie H. Kaplan Shel Source Type: research

The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort
Prostate Cancer and Prostatic Diseases, Published online: 02 December 2022; doi:10.1038/s41391-022-00623-5The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 2, 2022 Category: Urology & Nephrology Authors: Mariaconsiglia Ferriero Francesco Prata Riccardo Mastroianni Cosimo De Nunzio Giorgia Tema Gabriele Tuderti Alfredo Maria Bove Umberto Anceschi Aldo Brassetti Leonardo Misuraca Silvana Giacinti Fabio Calabr ò Salvatore Guaglianone Andrea Tubaro Rocco Pap Source Type: research

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review
Prostate Cancer and Prostatic Diseases, Published online: 01 December 2022; doi:10.1038/s41391-022-00613-7Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - December 1, 2022 Category: Urology & Nephrology Authors: Melissa Barlow Liz Down Luke Timothy Allan Mounce Samuel William David Merriel Jessica Watson Tanimola Martins Sarah Elizabeth Rose Bailey Source Type: research

Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 29 November 2022; doi:10.1038/s41391-022-00624-4Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resulting tumour-suppressive effect in trained patients with advanced prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 29, 2022 Category: Urology & Nephrology Authors: Jin-Soo Kim Dennis R. Taaffe Daniel A. Galv ão Timothy D. Clay Andrew D. Redfern Nicolas H. Hart Elin S. Gray Charles J. Ryan Stacey A. Kenfield Fred Saad Robert U. Newton Source Type: research

Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate?
Prostate Cancer and Prostatic Diseases, Published online: 29 November 2022; doi:10.1038/s41391-022-00617-3Reply to RE: Should LHRH therapy be continued in patients receiving Abiraterone Acetate? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 29, 2022 Category: Urology & Nephrology Authors: Carsten-Henning Ohlmann Source Type: research

Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study
Prostate Cancer and Prostatic Diseases, Published online: 29 November 2022; doi:10.1038/s41391-022-00625-3Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 29, 2022 Category: Urology & Nephrology Authors: Vincenzo Ficarra Marta Rossanese Manuel Gilante Mauro Foti Luciano Macchione Giuseppe Mucciardi Maurizio Martini Gianluca Giannarini Source Type: research

Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2022; doi:10.1038/s41391-022-00619-1Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2022 Category: Urology & Nephrology Authors: Christian Schaufler Sumedh Kaul Aaron Fleishman Ruslan Korets Peter Chang Andrew Wagner Simon Kim Joaquim Bellmunt Irving Kaplan Aria F. Olumi Boris Gershman Source Type: research

Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine
Prostate Cancer and Prostatic Diseases, Published online: 24 November 2022; doi:10.1038/s41391-022-00609-3Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 24, 2022 Category: Urology & Nephrology Authors: Filippo Marino Angelo Totaro Carlo Gandi Riccardo Bientinesi Stefano Moretto Filippo Gavi Francesco Pierconti Roberto Iacovelli PierFrancesco Bassi Emilio Sacco Source Type: research